港股異動 | 永聯豐控股午後突遭爆炒一度飆升60% 現漲幅收窄至12.5%
格隆匯11月20日丨永聯豐控股(8617.HK)午後突遭爆炒,一度暴漲超60%。繼而又極速回落,日K線呈一根長長的上影線。現漲幅收窄至12.5%,報0.63港元,暫成交6262萬港元,最新總市值2.5億港元。

公司剛上市幾日表現較為平淡,今日午後股價大幅拉昇,振幅高達64%。公司是迴轉支承製造商,於2018年位列中國迴轉支承製造商第五位。2017年及2018年收益分別為4397.2萬、4626.7萬港元。
此前,公開發售獲非常大幅超額認購,相當於公開發售項下初步可供認購公開發售股份的約62.67倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.